Preliminary Results of Coxsackievirus With Pembrolizumab In Advanced Melanoma

April 10, 2017
Ann W. Silk, MD

Ann W. Silk, MD, discusses preliminary results of the CAPRA trial, a phase 1B study of intratumoral coxsackievirus A21 (CVA21; CAVATAK) and systemic pembrolizumab in patients with advanced melanoma.